Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Kindred BiosciencesOptiNoseRecro PharmaMannKindCalithera Biosciences
SymbolNASDAQ:KINNASDAQ:OPTNNASDAQ:REPHNASDAQ:MNKDNASDAQ:CALA
Price Information
Current Price$10.26$7.46$16.88$1.56$7.47
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$14.44$24.83$15.50$2.83$7.50
% Upside from Price Target40.72% upside232.89% upside-8.18% downside81.62% upside0.40% upside
Trade Information
Market Cap$369.02 million$328.08 million$381.76 million$322 million$412.99 million
Beta0.30.78-0.312.462.26
Average Volume82,002165,844264,0842,288,950305,069
Sales & Book Value
Annual Revenue$1.97 million$7.07 million$77.35 million$27.86 million$22.25 million
Price / Sales203.5943.874.9611.5618.06
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.69 per share$2.88 per share($0.91) per share($1.10) per share$3.32 per share
Price / Book3.812.59-18.55-1.422.25
Profitability
Net Income$-49,690,000.00$-106,660,000.00$-79,720,000.00$-86,970,000.00$-54,630,000.00
EPS($1.60)($2.68)($2.49)($0.59)($1.49)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/A49.65N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,461.28%-419.37%-50.74%-75.13%N/A
Return on Equity (ROE)-58.86%-137.60%N/AN/A-71.14%
Return on Assets (ROA)-50.75%-61.40%-12.97%-49.16%-59.68%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.21%1.67%N/AN/A0.06%
Current Ratio9.30%4.81%8.07%0.96%7.39%
Quick Ratio8.88%4.66%6.79%0.90%7.39%
Ownership Information
Institutional Ownership Percentage67.52%71.64%61.05%26.50%64.91%
Insider Ownership Percentage12.63%44.30%20.10%1.02%17.20%
Miscellaneous
Employees14610225522579
Shares Outstanding39.09 million41.58 million22.73 million206.41 million53.78 million
Next Earnings Date3/4/2020 (Estimated)3/4/2020 (Estimated)2/25/2020 (Estimated)2/25/2020 (Confirmed)3/5/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel